TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
RYTM

Rhythm Pharmaceuticals Inc

Healthcare · Biotechnology

95.20$ -0.5% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

Rhythm Pharmaceuticals Inc (RYTM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -116 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow RYTM
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-18 -19 -7.5 -7.0 -23 -29 -62 -123 -122 -146 -173 -136 -114 -116
0.0 0.0 0.1 0.1 0.1 0.2 0.4 0.8 0.7 1.2 1.7 1.8 1.6 1.3
– 0.1 0.1 0.3 1.2 2.3 6.4 12 17 21 20 33 40 67
– – 0.1 1.7 1.2 4.1 6.4 12 17 21 20 – – –
0.2 2.0 -0.8 2.4 1.3 0.0 0.7 5.1 -5.9 1.9 -20 4.8 11 -1.0
0.0 0.0 0.0 0.0 1.1 0.1 0.7 3.4 0.2 5.4 4.3 0.0 0.0 1.0
-5.3 -5.1 0.0 0.0 -5.1 -110 -87 -28 159 -62 28 -5.7 -48 -137
– – – – – 0.0 – – – – – – 4.0 5.4
– – 7.4 42 126 167 165 163 2.0 166 141 – – –
– – – – – – – – – – 72 – – –
22 20 7.4 42 0.0 167 165 163 2.0 166 214 74 191 218
-0.7 -4.4 -0.1 35 -28 28 15 13 39 -42 68 -68 29 -35
-18 -19 -7.5 -7.0 -24 -30 -63 -126 -122 -151 -178 -136 -114 -117

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?